跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anavalin - SFDA Drug Approval Details
Approvals
/
SFDA
/
Anavalin
Authorized
GENERIC
Anavalin
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
9d02436319cd2343
Company
Unknown
Type
Generic
Approval Details
Approval Id
9d02436319cd2343
Drug Approval Sfda Name
Anavalin
Trade Name
Anavalin
Generic Name
CABAZITAXEL
Register Number
0102244830
Register Year
2024
Drug Type
Generic
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
6
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
do not store above 30°c
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000000186-10-100000073871
Price
11278.35
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
9d02436319cd2343
Type
Generic
Back to SFDA Approvals